Quick Answer
Allarity Therapeutics, Inc. reported Stockholders Equity of $9.83 million for fiscal year 2025.
Allarity Therapeutics, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $9.83M | -16.8% |
| 2024 | $11.81M | +529.3% |
| 2023 | -$2.75M | -2334.5% |
| 2022 | -$113.0K | -100.6% |
| 2021 | $18.15M | -25.7% |
| 2020 | $24.44M | +22.0% |
| 2019 | $20.04M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $12.01M | -7.4% | -1.3% |
| June 30, 2025 | $12.17M | -38.7% | -34.8% |
| March 31, 2025 | $18.67M | +388.5% | +58.1% |
| December 31, 2024 | $11.81M | +529.3% | -8.9% |
| September 30, 2024 | $12.96M | +483.7% | -34.6% |
| June 30, 2024 | $19.84M | +2843.4% | +406.5% |
| March 31, 2024 | -$6.47M | -108.6% | -135.2% |
| December 31, 2023 | -$2.75M | -2334.5% | +18.6% |
- Allarity Therapeutics, Inc. showed a decrease of -16.8% in Stockholders Equity compared to the prior fiscal year.
- Over the 2019–2025 period, Allarity Therapeutics, Inc.’s stockholders equity has declined by 50.9% (from $20.04 million to $9.83 million).
- The most recent figure is from Allarity Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: